CClinicalTrials.gg
CompletedNCT06068712Updated Oct 5, 2023

Proactive and Reactive Attention to Negative Templates

An interventional study of Attentional Cue Type in Healthy, sponsored by Lehigh University. Completed at 1 site in United States. Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-10-05.

Sponsored by Lehigh University · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Registered 8 years 7 months after the study started (first participant enrolled Oct 2014, registered May 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
19
Allocation
Not applicable
Ages
18 Years to 35 Years
Sex
All
01

Study summary

EEG Measures during Visual Search Task. In this line of research, the researchers having participants receive a positive (target) template cue, negative (distractor) template cue, or neutral (non-informative) template cue. Note: This is a re-analysis of previously collected data.

Read the detailed description

When finding a search target, receiving a target cue or distractor cue can increase search efficiency compared to a neutral cue. The researchers are examining the neural basis of visual search when participants receive a positive (target) cue, negative (distractor) cue, or neutral (baseline) cue. Note: This is a re-analysis of previously collected data.

02

Conditions studied

  • Healthy

Keywords

  • attention
  • visual search
  • electroencephalogram (EEG)
03

In context

Lead sponsor

Lehigh University is the lead sponsor of 16 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • normal or corrected to normal visual acuity, normal color vision, no history of neurological disorders

Exclusion criteria

Exclusion Criteria:

-

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
19 participants (actual)

Study arms

  • Experimental
    Within-Subjects Attentional Information

    All Participants receive all levels of the attentional cue (target, distractor, or neutral cue).

    Behavioral: Attentional Cue Type

Interventions

  • BehavioralAttentional Cue Type

    Positive cue (target), negative cue (distractor), or neutral cue (baseline)

06

What researchers measure

Primary outcomes

  1. Button Press Reaction Time

    Speed to respond correctly to the target- after participant finds the target shape on a computer screen, they press a button to indicate what shape they see

    Time frame: During Testing (single day)

  2. Button Press Accuracy

    Accuracy of responses to target item- we will measure whether the participants presses the correct button which corresponds to the target shape presented on the computer screen or the incorrect button

    Time frame: During Testing (single day)

  3. Proactive EEG Activity

    Proactive (pre-search) Measures of EEG Theta Activity

    Time frame: During Testing (single day)

  4. Reactive EEG Activity

    Reactive (post-search) Measures of EEG Alpha Activity

    Time frame: During Testing (single day)

07

Study locations

1 site
  • Lehigh University
    Bethlehem, Pennsylvania 18015, United States
08

References and documents

Individual participant data

Plan to share: Yes — We plan to share anonymized subject data on Open Science Framework.

Supporting information: Study protocol

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 5, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06068712
Lead sponsor
Lehigh University
Responsible party
Sponsor
First posted
Oct 5, 2023
Start date
Oct 11, 2014
Primary completion
Apr 2, 2015
Completion
Apr 2, 2015
Last update
Oct 5, 2023

Study contacts

Nancy Carlisle, PhD
principal investigator · Lehigh University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion